Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2019 / Mar / Putting a Bug in Your Ear
Microbiology & Immunology Genetics and epigenetics Microbiology and Immunology Precision medicine Screening and monitoring Infectious Disease

Putting a Bug in Your Ear

Gene variants may increase susceptibility to middle ear infections

By Michael Schubert 03/22/2019 Quick Read (pre 2022) 1 min read

Share

Middle ear infections are one of the most common ailments of childhood. But not everyone is equally susceptible – why? A research group at the University of Colorado’s Anschutz Medical Campus has discovered a way to identify those who may be more at risk. Describing for the first time the expression of the FUT2 gene in the middle ear (1), the researchers found that levels spike within 24 hours of bacterial infection, and also that certain variants of the gene alter the overall microbiome of the middle ear.

“FUT2 was identified as a protective locus against otitis media susceptibility in a genome-wide association study (2),” says first author Regie Santos-Cortez. “However, when we looked at the sequence data from our multi-ethnic families, we saw that the FUT2 variants conferred risk for otitis media.”

How does the gene interact with the microbiome to elevate the risk of disease? “Middle ear swabs in FUT2 variant carriers had greater bacterial diversity, meaning that the types of bacterial groups in variant carriers are different – and relatively higher in number – than in non-carriers,” Santos-Cortez explains. “This suggests that the bacterial load in the middle ear, including potential pathogens, is increased in those with genetic susceptibility to disease.” By decreasing the presentation of the A antigen bacteria use to enter the middle ear lining, the variants cause a shift in the microbiome, decreasing some bacterial populations and increasing others – including some known to promote chronic or recurrent infections.

What’s next? Santos-Cortez suggests that microbiota transplants might help restore the normal middle ear microbiome in variant carriers. “What we need to know at this point are the good commensal bacteria that we would want to restore to healthy levels to outcompete the pathogenic bacteria,” she says. “We would also want to have more directed therapies, such as antibiotic treatments, that target specific pathogenic bacteria without affecting the healthy commensals.” Meanwhile, she and her colleagues intend to continue finding genetic variants in relation to the middle ear microbiome to improve otitis media management in every population.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. RLP Santos-Cortez et al., “FUT2 variants confer susceptibility to familial otitis media”, Am J Hum Genet, 103, 679–690 (2018). PMID: 30401457. JK Pickrell et al., “Detection and interpretation of shared genetic influences on 42 human traits”, Nat Genet, 48, 709–717 (2016). PMID: 27182965.

About the Author(s)

Michael Schubert

While obtaining degrees in biology from the University of Alberta and biochemistry from Penn State College of Medicine, I worked as a freelance science and medical writer. I was able to hone my skills in research, presentation and scientific writing by assembling grants and journal articles, speaking at international conferences, and consulting on topics ranging from medical education to comic book science. As much as I’ve enjoyed designing new bacteria and plausible superheroes, though, I’m more pleased than ever to be at Texere, using my writing and editing skills to create great content for a professional audience.

More Articles by Michael Schubert

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Genetics and epigenetics
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Molecular Spectacular
Genetics and epigenetics
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Redefining Diagnostic Reference Standards
Genetics and epigenetics
Redefining Diagnostic Reference Standards

January 3, 2022

1 min read

Find out what Horizon Discovery’s diagnostic reference standards can do for your workflow

Defining the Next Generation of NGS
Genetics and epigenetics
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.